Evidence map›Paper›PMID 41264401›Full record

ReviewChemistry & biodiversity2026

Microalgae-Derived Metal Nanostructures: Biosynthesis, Characterization, and Applications.

Jaya Lakkakula, Palak Kalra, Hrutvik Mungaji, Penna Suprasanna, Ulhas S Kadam

Abstract readReview
In one paragraph

Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jaya LakkakulaAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai, India.
Palak KalraAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai, India.
Hrutvik MungajiAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai, India.
Penna SuprasannaAmity Institute of Biotechnology, Amity University Maharashtra, Mumbai, India.
Ulhas S KadamDivision of Applied Life Science (BK21 Four), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, Republic of Korea.ORCID https://orcid.org/0000-0001-8737-167X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exploration of green chemistry approaches for novel nanoparticles derived from microalgae presents a promising frontier in the realm of biomedical applications, harnessing the unique properties of these microorganisms for innovative solutions in healthcare. Microalgae, mainly due to their rapid growth rates and ability to synthesize diverse bioactive compounds, have become an environmentally friendly, green chemistry method to produce nanoparticles, overcoming current toxic chemical approaches. This review study aims to clarify the processes that underlie the biosynthesis of different microalgal species' nanoparticles and the ensuing biomedical uses. The study investigates the manufacturing of copper, gold, iron, and silver nanoparticles and the optimization of other parameters, including pH and metal ion concentration. Characterization techniques such as UV-Vis spectroscopy, FTIR, TEM, and XRD revealed particle sizes ranging from 2 to 149 nm with distinct crystalline structures. Notably, microalgae-derived silver nanoparticles exhibited strong antioxidant activity (e.g., 77.01% DPPH and 88.12% ABTS scavenging at 500 µg/mL), potent antibacterial action (minimum inhibitory concentrations as low as 5 µg/mL for Escherichia coli), and selective cytotoxicity against cancer cell lines (IC

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsMetal NanoparticlesMicroalgaeAntioxidantsEscherichia coliHumansMicrobial Sensitivity TestsSilverAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsSilverbioactive compoundsbiomedical applicationsbiosynthesisgreen chemistrymicroalgaenanoparticles

Identifiers

PMID41264401
PMCPMC13421865

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.